Guo-Guang Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guo-Guang Ma has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Dong Li
Department of Orthopaedics, Linzi District People's Hospital of Shandong Province, No. 139 Henggong Road, Linzi District, Zibo, Shandong, China
1 shared publication
Latest Publications
- 26 November 2015
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
- Vol. 24 (8) , 2614-2619
Analgesic efficacy and quadriceps strength of adductor canal block versus femoral nerve block following total knee arthroplasty
Femoral nerve blocks (FNBs) provide effective analgesia after total knee arthroplasty, but have been associated with quadriceps weakness. Adductor canal block (ACB) is a promising alternative option that delivers a primarily sensory blockade. The aim of this study was to determine whether ACB provides superior quadriceps strength and similar pain control than FNB. A systematic search of PubMed, the Cochrane Library, EMBASE and Web of Science was conducted without publication data or language restriction. Comparative studies comparing ACB with FNB were included. Two authors independently assessed data extraction and quality of the studies. Nine studies with 639 patients were identified. Results of meta-analysis showed that compared with FNB, ACB preserved quadriceps muscle strength better than FNB [MD24h = 1.14, 95 % CI (0.38, 1.91), p < 0.01; MD48h = 0.40, 95 % CI (0.16, 0.64), p < 0.01], while there were no significant differences in pain score during rest at 24 h [SMD = − 0.04, 95 % CI (−0.17, 0.26); n.s] or 48 h [SMD = − 0.10, 95 % CI (−0.27, 0.08); n.s], pain score during activity at 24 h [SMD = 0.13, 95 % CI (−0.36, 0.62); n.s] or 48 h [SMD = − 0.13, 95 % CI (−0.37, 0.12); n.s], opioid consumption at 24 h [SMD = − 0.01, 95 % CI (−1.68, 1.66); n.s] or 48 h [SMD = − 0.92, 95 % CI (−6.86, 5.01); n.s], length of hospital stay [MD = 0.05, 95 % CI (−0.91, 1.00); n.s] and nausea or vomiting [RR = 1.17, 95 % CI (0.62, 2.20); n.s] between ACB and FNB. ACB preserved the strength of quadriceps more than FNB and achieves similar analgesic effects in post-operative pain. Level III.
- 26 November 2015
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
- Vol. 24 (8) , 2614-2619
Analgesic efficacy and quadriceps strength of adductor canal block versus femoral nerve block following total knee arthroplasty
Femoral nerve blocks (FNBs) provide effective analgesia after total knee arthroplasty, but have been associated with quadriceps weakness. Adductor canal block (ACB) is a promising alternative option that delivers a primarily sensory blockade. The aim of this study was to determine whether ACB provides superior quadriceps strength and similar pain control than FNB. A systematic search of PubMed, the Cochrane Library, EMBASE and Web of Science was conducted without publication data or language restriction. Comparative studies comparing ACB with FNB were included. Two authors independently assessed data extraction and quality of the studies. Nine studies with 639 patients were identified. Results of meta-analysis showed that compared with FNB, ACB preserved quadriceps muscle strength better than FNB [MD24h = 1.14, 95 % CI (0.38, 1.91), p < 0.01; MD48h = 0.40, 95 % CI (0.16, 0.64), p < 0.01], while there were no significant differences in pain score during rest at 24 h [SMD = − 0.04, 95 % CI (−0.17, 0.26); n.s] or 48 h [SMD = − 0.10, 95 % CI (−0.27, 0.08); n.s], pain score during activity at 24 h [SMD = 0.13, 95 % CI (−0.36, 0.62); n.s] or 48 h [SMD = − 0.13, 95 % CI (−0.37, 0.12); n.s], opioid consumption at 24 h [SMD = − 0.01, 95 % CI (−1.68, 1.66); n.s] or 48 h [SMD = − 0.92, 95 % CI (−6.86, 5.01); n.s], length of hospital stay [MD = 0.05, 95 % CI (−0.91, 1.00); n.s] and nausea or vomiting [RR = 1.17, 95 % CI (0.62, 2.20); n.s] between ACB and FNB. ACB preserved the strength of quadriceps more than FNB and achieves similar analgesic effects in post-operative pain. Level III.